Integrated characterization of SARS-CoV-2 genome, microbiome, antibiotic resistance and host response from single throat swabs
This article has been Reviewed by the following groups
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
- Evaluated articles (ScreenIT)
Abstract
The ongoing coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, poses a severe threat to humanity. Rapid and comprehensive analysis of both pathogen and host sequencing data is critical to track infection and inform therapies. In this study, we performed unbiased metatranscriptomic analysis of clinical samples from COVID-19 patients using a newly-developed RNA-seq library construction method (TRACE-seq), which utilizes tagmentation activity of Tn5 on RNA/DNA hybrids. This approach avoids the laborious and time-consuming steps in traditional RNA-seq procedure, and hence is fast, sensitive and convenient. We demonstrated that TRACE-seq allowed integrated characterization of full genome information of SARS-CoV-2, putative pathogens causing coinfection, antibiotic resistance and host response from single throat swabs. We believe that the integrated information will deepen our understanding of pathogenesis and improve diagnostic accuracy for infectious diseases.
Article activity feed
-
SciScore for 10.1101/2020.10.15.340794: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement IRB: Ethics statement: The study and use of all samples were approved by the Ethics Committee of Wuhan Institue of Virology (No. WIVH17202001). Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources preprocessing: Raw reads from sequencing were firstly subjected to Trim Galore (v0.6.4_dev) (http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/) for quality control and adaptor trimming. Trim Galoresuggested: (Trim Galore, RRID:SCR_011847)Host transcriptional profiling analysis: Filtered reads were mapped to human genome (hg19) and … SciScore for 10.1101/2020.10.15.340794: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement IRB: Ethics statement: The study and use of all samples were approved by the Ethics Committee of Wuhan Institue of Virology (No. WIVH17202001). Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources preprocessing: Raw reads from sequencing were firstly subjected to Trim Galore (v0.6.4_dev) (http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/) for quality control and adaptor trimming. Trim Galoresuggested: (Trim Galore, RRID:SCR_011847)Host transcriptional profiling analysis: Filtered reads were mapped to human genome (hg19) and transcriptome using STAR (v2.7.1a) (35). STARsuggested: (STAR, RRID:SCR_015899)Multidimensional scaling and differential gene expression analysis were conducted using EdgeR (v3.28.1) (37) with gene count data generated by HTSeq (v0.11.2) (38). EdgeRsuggested: (edgeR, RRID:SCR_012802)HTSeqsuggested: (HTSeq, RRID:SCR_005514)Gene Ontology Enrichment Analysis for biological processes was performed by DAVID (v6.8) (39) with all significantly up-regulated genes as input. DAVIDsuggested: (DAVID, RRID:SCR_001881)Due to the redundancy of enriched GO terms, GO terms and their p values were further summarized using REViGO (40). REViGOsuggested: (REViGO, RRID:SCR_005825)Discrimination and de-novo assembly of SARS-CoV-2: After removal of human reads, the remaining data were aligned to the reference genome of Wuhan-Hu-1 (GenBank accession number: NC_045512) using Bowtie2 (v2.2.9) (41) for SARS-CoV-2 identification. Bowtie2suggested: (Bowtie 2, RRID:SCR_016368)The coverage and sequencing depth of SARS-CoV-2 genome were calculated by Samtools (v1.9) (42). Samtoolssuggested: (SAMTOOLS, RRID:SCR_002105)On the other hand, to verify the method could screen for aetiologic agents and obtain pathogen genome, all non-human reads were processed for de-novo assembly using MEGAHIT (v1.2.9) with default parameters (43), and then all contigs were searched against NCBI nt database using blastn for classification(44). MEGAHITsuggested: (MEGAHIT, RRID:SCR_018551)blastnsuggested: (BLASTN, RRID:SCR_001598)Microbiome analysis: After removing human reads, the remaining reads were subjected to microbial taxonomic classification using Kraken2 (v2.0.8-beta) (45) with a custom database. Kraken2suggested: NoneTo build the custom database, standard RefSeq complete bacterial genomes were downloaded through “kraken2-build --download-library bacteria” and complete genomes of human viruses and genome assemblies of fungi were downloaded from NCBI’s RefSeq and added to the custom database’s genomic library using the “--add-to-library” switch. RefSeqsuggested: (RefSeq, RRID:SCR_003496)Distances between samples were calculated using Morisita-horn dissimilarity index by vegdist command from vegan package version 2.5-6 (https://CRAN.R-project.org/package=vegan). vegansuggested: (vegan, RRID:SCR_011950)All corresponding graphs were plotted using R scripts by RStudio (v1.2.5033) (https://rstudio.com/). RStudiosuggested: (RStudio, RRID:SCR_000432)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-
